All Harm, No Help in 340B Cuts
Now that a U.S. District Court has postponed the hospital industry’s legal challenge to cutbacks in the 340B drug discount program, it falls to
CMS 340B Reimbursement Cuts Cause Big Pharma Profits While Underserved Patients Lose
As you and your readers may now be aware, the 340B Drug Pricing Program has been under siege for the past couple months. The program requires drug
House Gears Up for 340B Oversight Push
Pressure over the status of a federal drug discount program has intensified on Capitol Hill as Medicare reimbursement cuts for 340B hospitals have
Letter: 340B program is working as intended
Rena Conti’s Dec. 18 column “340B effort is in need of reforms” mischaracterizes the 340B drug discount program and undervalues how essential it is to
Lifesaving 340B Discount Drug Program Under Attack
CLEVELAND — I met Hope (not her real name) at the MetroHealth Cancer Center a year and a half ago – a happily married young woman who had a